Use of Dietary Management in Irritable Bowel Syndrome: Results of a Survey of Over 1500 United States Gastroenterologists
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Background/AimsDietary therapy is increasingly used to manage gastrointestinal (GI) symptoms in patients with irritable bowel syndrome (IBS).We aim to gauge United States gastroenterologists' perceptions of dietary therapies for IBS. MethodsWe distributed a 22-question survey to members of the American College of Gastroenterology.The survey was developed by gastroenterologists and survey methodologists.We collected information pertaining to demographics, providers' interpretation of their patients' views on dietary therapy, and gastroenterologists' perceptions on dietary therapy, and nutritional counseling in IBS. ResultsOne thousand five hundred and sixty-two (14%) surveys were collected.Nearly 60% of participants reported that patients commonly associate food with GI symptoms.IBS patients most commonly use a trial and error approach followed by a lactose-free and glutenfree diet, and rarely use a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet on their own.Over half of providers recommend diet therapy to > 75% of IBS patients and most commonly recommend a low FODMAP diet.Only 21% of gastroenterologists commonly refer IBS patients to registered dietitians, and only 30% use GI dietitians.Female providers were more likely than males to recommend dietary changes as the primary mode of therapy (OR, 1.43 [1.09-1.88];P = 0.009). ConclusionsOur national survey identified enthusiasm for diet treatment of IBS.While patients infrequently tried a low FODMAP diet on their own, GI providers commonly recommended this diet.Only a minority of GI providers refer their IBS patients to a registered dietitian for nutrition counseling and few refer patients to dietitians with specialized GI training.Female providers were more enthusiastic about diet therapies than males.(
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155
AGA technical review on irritable bowel syndrome.
Drossman, D. A., Camilleri, M., Mayer, E. A., & Whitehead, W. E. (2002) · Gastroenterology · doi:10.1053/gast.2002.37095 · Cited by 1,384
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Böhn, L., Störsrud, S., Törnblom, H., Bengtsson, U., & Simrén, M. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.105 · Cited by 655 · cited 1×
“The association between food intake and GI symptoms is commonly based on previously published surveys of IBS patients.(9) Similarly, our study found that GI providers believe that almost 60% of IBS patients relate their GI symptoms to eating a meal.”
ResultStaudacher, H. M., Lomer, M. C. E., Anderson, J. L., Barrett, J. S., Muir, J. G., Irving, P. M., & Whelan, K. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.159285 · Cited by 590 · cited 1×
“Recent randomized, controlled trials suggest that diet therapies provide adequate relief to 50-70% of IBS sufferers.(17,19,24,25) This compares quite favorably to the efficacy of Food and Drug Administration approved medical therapies for IBS, which typically provide adequate relief of GI symptoms in 20-60% of patient…”
BackgroundOng, D. K., Mitchell, S. B., Barrett, J. S., Shepherd, S. J., Irving, P. M., Biesiekierski, J. R., Smith, S., Gibson, P. R., & Muir, J. G. (2010) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06370.x · Cited by 583 · cited 1×
“Multiple observational and randomized controlled trials have demonstrated that a low FODMAP diet may reduce the frequency and severity of GI symptoms in IBS patients.(19,24,25,34,35) However, it is important to note that long-term efficacy and safety data are currently lacking and many of the existing studies have sig…”
BackgroundFood-Related gastrointestinal symptoms in the irritable bowel syndrome
Simrén, M., Månsson, A., Langkilde, A. M., Svedlund, J., Abrahamsson, H., Bengtsson, U., & Björnsson, E. S. (2001) · Digestion · doi:10.1159/000051878 · Cited by 529
Chey, W. D., Lembo, A. J., Lavins, B. J., Shiff, S. J., Kurtz, C. B., Currie, M. G., MacDougall, J. E., Jia, X. D., Shao, J. Z., Fitch, D. A., et al. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.254 · Cited by 463
Self-citationMedical costs in community subjects with irritable bowel syndrome
Talley, N. J., Gabriel, S. E., Harmsen, W. S., Zinsmeister, A. R., & Evans, R. W. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90738-6 · Cited by 460 · cited 1×
“IBS is associated with a high morbidity and accounts for billions of dollars in direct and indirect medical costs in the United States (US).(5,6) The pathogenesis of this disorder is exceedingly complex and likely multifactorial, secondary to abnormalities in motility, visceral sensation, brain-gut interactions, intes…”
BackgroundStaudacher, H. M., Lomer, M. C. E., Farquharson, F. M., Louis, P., Fava, F., Franciosi, E., Scholz, M., Tuohy, K. M., Lindsay, J. O., Irving, P. M., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.010 · Cited by 430 · cited 2×
“Of course, this statement could fairly be applied to all dietary interventions offered to IBS patients, and many of the previous criticisms of the low FODMAP diet trials have recently been addressed in a study by Staudacher et al.(36) The results of our study indicate that the majority of US GI providers are conscious…”
ResultDROSSMAN, D. A., CHEY, W. D., JOHANSON, J. F., FASS, R., SCOTT, C., PANAS, R., & UENO, R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03881.x · Cited by 399
Self-citationMonsbakken, K. W., Vandvik, P. O., & Farup, P. G. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602367 · Cited by 364
Mayer, E. A. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0801447 · Cited by 243
Cited by
Behavioral and Diet Therapies in Integrated Care for Patients With Irritable Bowel Syndrome
Chey, W. D., Keefer, L., Whelan, K., & Gibson, P. R. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.06.099 · Cited by 154
Self-citationControversies and reality of the FODMAP diet for patients with irritable bowel syndrome
Halmos, E. P., & Gibson, P. R. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14650 · Cited by 112
The role of diet in irritable bowel syndrome: implications for dietary advice
Rej, A., Aziz, I., Tornblom, H., Sanders, D. S., & Simrén, M. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12966 · Cited by 61
Burton Murray, H., Weeks, I., Becker, K. R., Ljótsson, B., Madva, E. N., Eddy, K. T., Staller, K., Kuo, B., & Thomas, J. J. (2023) · International Journal of Eating Disorders · doi:10.1002/eat.23874 · Cited by 39
Metadata
- Authors
- Lenhart, A., Ferch, C., Shaw, M., & Chey, W. D.
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2018-07-30
- Volume
- 24
- Issue
- 3
- Pages
- 437-451
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- OpenAlex
- W2808173364
- Cited by
- 93
- References
- 13
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.